We are proud to be participating in Healx's webinar on the development of in vitro models for rare disease research on August 13. CureSHANK President and Co-Founder Geraldine Bliss, whose son Charles has Phelan-McDermid Syndrome, will discuss initiating collaborations for modeling diseases .
In vitro modeling is the first step in developing therapies for rare diseases like PMS. This step of the research process is conducted via test tubes or cell culture. After therapies are found successful in vitro, they are tested on animals, and then finally on humans in clinical trials.